These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 30899051)

  • 1. Targeting cellular metabolism to reduce head and neck cancer growth.
    Yang J; Guo Y; Seo W; Zhang R; Lu C; Wang Y; Luo L; Paul B; Yan W; Saxena D; Li X
    Sci Rep; 2019 Mar; 9(1):4995. PubMed ID: 30899051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic Targeting of the GLS1-c-Myc Positive Feedback Loop Suppresses Glutaminolysis and Inhibits Progression of Head and Neck Cancer.
    Yang J; Chen F; Lang L; Yang F; Fu Z; Martinez J; Cho A; Saba NF; Teng Y
    Cancer Res; 2024 Oct; 84(19):3223-3234. PubMed ID: 39024547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular targeting of glutaminase sensitizes ovarian cancer cells to chemotherapy.
    Masamha CP; LaFontaine P
    J Cell Biochem; 2018 Jul; 119(7):6136-6145. PubMed ID: 29633308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic Effects of Glutamine Deprivation and Metformin in Acute Myeloid Leukemia.
    Liu TY; Fu X; Yang Y; Gu J; Xiao M; Li DJ
    Curr Med Sci; 2024 Aug; 44(4):799-808. PubMed ID: 39096478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glutaminase-1 stimulates the proliferation, migration, and survival of human endothelial cells.
    Peyton KJ; Liu XM; Yu Y; Yates B; Behnammanesh G; Durante W
    Biochem Pharmacol; 2018 Oct; 156():204-214. PubMed ID: 30144404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual targeting of glutaminase 1 and thymidylate synthase elicits death synergistically in NSCLC.
    Lee JS; Kang JH; Lee SH; Hong D; Son J; Hong KM; Song J; Kim SY
    Cell Death Dis; 2016 Dec; 7(12):e2511. PubMed ID: 27929535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockade of glutamine-dependent cell survival augments antitumor efficacy of CPI-613 in head and neck cancer.
    Lang L; Wang F; Ding Z; Zhao X; Loveless R; Xie J; Shay C; Qiu P; Ke Y; Saba NF; Teng Y
    J Exp Clin Cancer Res; 2021 Dec; 40(1):393. PubMed ID: 34906193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination therapy with BPTES nanoparticles and metformin targets the metabolic heterogeneity of pancreatic cancer.
    Elgogary A; Xu Q; Poore B; Alt J; Zimmermann SC; Zhao L; Fu J; Chen B; Xia S; Liu Y; Neisser M; Nguyen C; Lee R; Park JK; Reyes J; Hartung T; Rojas C; Rais R; Tsukamoto T; Semenza GL; Hanes J; Slusher BS; Le A
    Proc Natl Acad Sci U S A; 2016 Sep; 113(36):E5328-36. PubMed ID: 27559084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glutaminase 1 Inhibition Reduces Glycolysis and Ameliorates Lupus-like Disease in MRL/lpr Mice and Experimental Autoimmune Encephalomyelitis.
    Kono M; Yoshida N; Maeda K; Suárez-Fueyo A; Kyttaris VC; Tsokos GC
    Arthritis Rheumatol; 2019 Nov; 71(11):1869-1878. PubMed ID: 31233276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glutamine metabolism via glutaminase 1 in autosomal-dominant polycystic kidney disease.
    Soomro I; Sun Y; Li Z; Diggs L; Hatzivassiliou G; Thomas AG; Rais R; Parker SJ; Slusher BS; Kimmelman AC; Somlo S; Skolnik EY
    Nephrol Dial Transplant; 2018 Aug; 33(8):1343-1353. PubMed ID: 29420817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the interactions of potent allosteric inhibitors with glutaminase C, a key enzyme in cancer cell glutamine metabolism.
    Huang Q; Stalnecker C; Zhang C; McDermott LA; Iyer P; O'Neill J; Reimer S; Cerione RA; Katt WP
    J Biol Chem; 2018 Mar; 293(10):3535-3545. PubMed ID: 29317493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glutaminolysis is a metabolic route essential for survival and growth of prostate cancer cells and a target of 5α-dihydrotestosterone regulation.
    Cardoso HJ; Figueira MI; Vaz CV; Carvalho TMA; Brás LA; Madureira PA; Oliveira PJ; Sardão VA; Socorro S
    Cell Oncol (Dordr); 2021 Apr; 44(2):385-403. PubMed ID: 33464483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibiting glutaminase in acute myeloid leukemia: metabolic dependency of selected AML subtypes.
    Matre P; Velez J; Jacamo R; Qi Y; Su X; Cai T; Chan SM; Lodi A; Sweeney SR; Ma H; Davis RE; Baran N; Haferlach T; Su X; Flores ER; Gonzalez D; Konoplev S; Samudio I; DiNardo C; Majeti R; Schimmer AD; Li W; Wang T; Tiziani S; Konopleva M
    Oncotarget; 2016 Nov; 7(48):79722-79735. PubMed ID: 27806325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glutaminase 1 regulates the release of extracellular vesicles during neuroinflammation through key metabolic intermediate alpha-ketoglutarate.
    Wu B; Liu J; Zhao R; Li Y; Peer J; Braun AL; Zhao L; Wang Y; Tong Z; Huang Y; Zheng JC
    J Neuroinflammation; 2018 Mar; 15(1):79. PubMed ID: 29540215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting glutaminolysis has antileukemic activity in acute myeloid leukemia and synergizes with BCL-2 inhibition.
    Jacque N; Ronchetti AM; Larrue C; Meunier G; Birsen R; Willems L; Saland E; Decroocq J; Maciel TT; Lambert M; Poulain L; Hospital MA; Sujobert P; Joseph L; Chapuis N; Lacombe C; Moura IC; Demo S; Sarry JE; Recher C; Mayeux P; Tamburini J; Bouscary D
    Blood; 2015 Sep; 126(11):1346-56. PubMed ID: 26186940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of lysine to alanine mutations on the phosphate activation and BPTES inhibition of glutaminase.
    McDonald CJ; Acheff E; Kennedy R; Taylor L; Curthoys NP
    Neurochem Int; 2015 Sep; 88():10-4. PubMed ID: 25510640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted inhibition of tumor-specific glutaminase diminishes cell-autonomous tumorigenesis.
    Xiang Y; Stine ZE; Xia J; Lu Y; O'Connor RS; Altman BJ; Hsieh AL; Gouw AM; Thomas AG; Gao P; Sun L; Song L; Yan B; Slusher BS; Zhuo J; Ooi LL; Lee CG; Mancuso A; McCallion AS; Le A; Milone MC; Rayport S; Felsher DW; Dang CV
    J Clin Invest; 2015 Jun; 125(6):2293-306. PubMed ID: 25915584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glutamine deprivation plus BPTES alters etoposide- and cisplatin-induced apoptosis in triple negative breast cancer cells.
    Chen L; Cui H; Fang J; Deng H; Kuang P; Guo H; Wang X; Zhao L
    Oncotarget; 2016 Aug; 7(34):54691-54701. PubMed ID: 27419628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting GLS1 to cancer therapy through glutamine metabolism.
    Yu W; Yang X; Zhang Q; Sun L; Yuan S; Xin Y
    Clin Transl Oncol; 2021 Nov; 23(11):2253-2268. PubMed ID: 34023970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis, and pharmacological evaluation of bis-2-(5-phenylacetamido-1,2,4-thiadiazol-2-yl)ethyl sulfide 3 (BPTES) analogs as glutaminase inhibitors.
    Shukla K; Ferraris DV; Thomas AG; Stathis M; Duvall B; Delahanty G; Alt J; Rais R; Rojas C; Gao P; Xiang Y; Dang CV; Slusher BS; Tsukamoto T
    J Med Chem; 2012 Dec; 55(23):10551-63. PubMed ID: 23151085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.